IL140667A0 - Compositions containing at least one active substance having an influence on the levels of lipids in the blood - Google Patents

Compositions containing at least one active substance having an influence on the levels of lipids in the blood

Info

Publication number
IL140667A0
IL140667A0 IL14066799A IL14066799A IL140667A0 IL 140667 A0 IL140667 A0 IL 140667A0 IL 14066799 A IL14066799 A IL 14066799A IL 14066799 A IL14066799 A IL 14066799A IL 140667 A0 IL140667 A0 IL 140667A0
Authority
IL
Israel
Prior art keywords
lipids
blood
levels
influence
active substance
Prior art date
Application number
IL14066799A
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of IL140667A0 publication Critical patent/IL140667A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061Polyacrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/366Lactones having six-membered rings, e.g. delta-lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL14066799A 1998-07-09 1999-07-07 Compositions containing at least one active substance having an influence on the levels of lipids in the blood IL140667A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19830732A DE19830732B4 (en) 1998-07-09 1998-07-09 Composition containing at least one substance influencing blood lipid levels and its use
PCT/EP1999/004757 WO2000002541A1 (en) 1998-07-09 1999-07-07 Transdermal plaster containing at least one active ingredient which influences blood serum lipid levels

Publications (1)

Publication Number Publication Date
IL140667A0 true IL140667A0 (en) 2002-02-10

Family

ID=7873488

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14066799A IL140667A0 (en) 1998-07-09 1999-07-07 Compositions containing at least one active substance having an influence on the levels of lipids in the blood
IL140667A IL140667A (en) 1998-07-09 2001-01-01 Compositions containing at least one active substance having an influence on the levels of lipids in the blood

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL140667A IL140667A (en) 1998-07-09 2001-01-01 Compositions containing at least one active substance having an influence on the levels of lipids in the blood

Country Status (22)

Country Link
EP (1) EP1094797B1 (en)
JP (1) JP2002520272A (en)
KR (1) KR100549848B1 (en)
CN (1) CN1309377C (en)
AR (1) AR019902A1 (en)
AT (1) ATE278395T1 (en)
AU (1) AU770573B2 (en)
BR (1) BR9911941A (en)
CA (1) CA2336712C (en)
CZ (1) CZ300976B6 (en)
DE (2) DE19830732B4 (en)
ES (1) ES2230872T3 (en)
HU (1) HU226614B1 (en)
IL (2) IL140667A0 (en)
MX (1) MXPA01000126A (en)
NZ (1) NZ509215A (en)
PL (1) PL194983B1 (en)
RU (1) RU2227023C2 (en)
TR (1) TR200100021T2 (en)
TW (1) TWI237572B (en)
WO (1) WO2000002541A1 (en)
ZA (1) ZA200100171B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL189890B1 (en) * 1999-09-14 2005-10-31 Kazmierski Jan Zaklad Prod Usl Preparation for protecting plants against diseases
WO2004026297A1 (en) * 2002-09-20 2004-04-01 Kowa Co., Ltd. Preparation for external use
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
AU2004203700B2 (en) * 2003-01-02 2007-06-21 Femmepharma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
WO2005094814A1 (en) * 2004-03-31 2005-10-13 Kowa Co., Ltd. External preparation
JP4986411B2 (en) * 2004-06-01 2012-07-25 久光製薬株式会社 Patch
US8173155B2 (en) 2004-06-01 2012-05-08 Hisamitsu Pharmaceutical Co., Inc. Adhesive patch
US20050281868A1 (en) * 2004-06-21 2005-12-22 Fairfield Clinical Trials, Llc Transdermal delivery system for statin combination therapy
DE102004062182B4 (en) * 2004-12-20 2007-06-06 Bayer Schering Pharma Ag Transdermal patch with progesterone A-specific ligands (PRASL) as active ingredient
CA2644851A1 (en) * 2006-03-07 2007-09-13 Osteoscreen Ip, Llc Hmg co-a reductase inhibitor enhancement of bone and cartilage
KR100817274B1 (en) * 2006-08-21 2008-03-27 삼성전기주식회사 Light emitting diode package and method of manufacturing the same
WO2018115535A1 (en) 2016-12-19 2018-06-28 Nutritape, S.L. Energising patch for sportspeople
CN113573794B (en) * 2019-03-12 2023-06-16 康宁股份有限公司 Ceramic honeycomb body with skin
TWI803052B (en) * 2021-11-12 2023-05-21 佛教慈濟醫療財團法人 Transdermal delivery device, methods of using and making the same

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3634016A1 (en) * 1986-04-17 1987-10-29 Lohmann Gmbh & Co Kg AREA-BASED THERAPEUTIC SYSTEM, METHOD FOR THE PRODUCTION THEREOF AND ITS USE
US5503844A (en) * 1993-05-18 1996-04-02 Mli Acquisition Corp. Ii Foam laminate transdermal patch
FR2719220A1 (en) * 1994-04-29 1995-11-03 Lafon Labor New galenic form for transdermal administration.
DE69524614T2 (en) * 1994-10-05 2002-09-12 Hisamitsu Pharmaceutical Co., Inc. MEDICINAL COMPONENTS, INCLUDING AN N-SUBSTITUTED O-TOLUIDE INDEXIVATIVE AND TRANSDERMALLY ABSORBABLE PREPARATION
DE19541260A1 (en) * 1995-11-06 1997-05-07 Lohmann Therapie Syst Lts Therapeutic preparation for transdermal application of active ingredients through the skin
WO1999024032A1 (en) * 1997-11-10 1999-05-20 Novo Nordisk A/S Transdermal delivery of 3,4-diarylchromans

Also Published As

Publication number Publication date
IL140667A (en) 2007-05-15
EP1094797A1 (en) 2001-05-02
RU2227023C2 (en) 2004-04-20
CA2336712C (en) 2008-09-09
ES2230872T3 (en) 2005-05-01
DE19830732B4 (en) 2008-11-13
PL194983B1 (en) 2007-07-31
NZ509215A (en) 2003-04-29
TR200100021T2 (en) 2001-05-21
AR019902A1 (en) 2002-03-20
BR9911941A (en) 2001-03-27
TWI237572B (en) 2005-08-11
ATE278395T1 (en) 2004-10-15
EP1094797B1 (en) 2004-10-06
JP2002520272A (en) 2002-07-09
MXPA01000126A (en) 2002-06-04
WO2000002541A1 (en) 2000-01-20
CN1309377C (en) 2007-04-11
PL345510A1 (en) 2001-12-17
AU770573B2 (en) 2004-02-26
CN1308525A (en) 2001-08-15
HU226614B1 (en) 2009-04-28
HUP0102718A3 (en) 2002-12-28
HUP0102718A2 (en) 2002-03-28
DE19830732A1 (en) 2000-01-13
DE59910758D1 (en) 2004-11-11
CZ200193A3 (en) 2001-05-16
KR100549848B1 (en) 2006-02-06
KR20010079513A (en) 2001-08-22
CA2336712A1 (en) 2000-01-20
ZA200100171B (en) 2001-08-10
CZ300976B6 (en) 2009-09-30
AU5157499A (en) 2000-02-01

Similar Documents

Publication Publication Date Title
EP0981649A4 (en) Peptides which enhance transport of an active agent across tissues and compositions and methods of using the same
HUP0400887A3 (en) Glycopeptide derivatives and pharmaceutical compositions containing the same
HUP0105089A3 (en) Compositions containing the active ingredient in form dispersible phospholipid stabilized microparticles
IL140862A (en) Thiobenzimidazole derivatives and pharmaceutical compositions containing the same
FI973828A (en) Compounds and compositions for administering the active ingredients
HUP0103707A3 (en) Formulation of stable oxalyplatinum solution
PL347310A1 (en) Combination of two or more active ingredients using microencapsulated formulations
ZA992549B (en) Incorporation of active substances in carrier matrixes.
HUP0103925A3 (en) Storable active substance concentrate containing formoterol
IL135646A0 (en) α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
SI1419789T1 (en) Preparation of a lipid blend and a phospholipid suspension containing the lipid blend, and contrast agents based on these
IL138725A0 (en) Sulfonamide derivatives and pharmaceutical compositions containing the same
IL140667A0 (en) Compositions containing at least one active substance having an influence on the levels of lipids in the blood
GB9827964D0 (en) Active backplane circuitry
HU9802795D0 (en) Pharmaceutical compositions containing more active components
IL143802A0 (en) Imidazole derivatives and pharmaceutical compositions containing the same
GB2323037B (en) Evaluating the fit of an orthopaedic implant
NZ318391A (en) Fungicidal compositions comprising fenazaquine as an active substance
DE69919490D1 (en) POWDER WITH FAT-SOLUBLE ACTIVE SUBSTANCE
IL127439A0 (en) Precipitated silicas which contain an active substance
IL136612A0 (en) Phenylaminoalkylcarboxylic acid derivatives and medical compositions containing the same
SG68529A1 (en) The use of des-aspartate-angiotensin i (agr-val-tyr-ile-his-pro-phe-his-leu) as an anti-cardiac hypertrophic agent
IL142534A0 (en) Pharmaceutical compositions containing an antigen-adjuvent
HK1043125A1 (en) Sulphonyloxazolamines as therapeutic active ingredients
IL138994A0 (en) 2-methylpropionic acid derivatives and medicinal compositions containing the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed